Enigma Diagnostics Licenses Rights to ABI's '907 Real-Time PCR Patent | GenomeWeb
NEW YORK (GenomeWeb News) – UK molecular diagnostics company Enigma Diagnostics said today that it has licensed access to an Applied Biosystems patent for real-time detection of nucleic acid amplification products.
 
The Porton Down, UK-based company, which specializes in decentralized and point-of-care diagnostics, said it has licensed access to US Patent No. 5,928,907, “System for real time detection of nucleic acid amplification products.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.